Back to CAPTRUST FINANCIAL ADVISORS CAPTRUST FINANCIAL ADVISORS

AIMTAIMT
3 quarters

Position history for CAPTRUST FINANCIAL ADVISORSCAPTRUST FINANCIAL ADVISORS's holdings in AIMMUNE THERAPEUTICS INC

As of its Q3 2020 13F, Captrust held 100 shares of AIMT (Aimmune Therapeutics), worth $3,000. Captrust's 13F filings listed AIMT from Q2 2020 to Q3 2020, 2 quarterly filings.

Final Value

$0

Final Shares

0

Total Value Change

-$4,000

Total Shares Change

-265

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2020-Q4
Latest
Exited
0
-100.0%
$00.0%—
0
2020-Q3
Decreased
100
-62.3%
$3,0000.0%—
0
2020-Q2
New
265
-
$4,0000.0%—
20

Other major holders of AIMT: PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, Pentwater Capital Management LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used